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Purpose: In longitudinal oncological and brain PET/CT studies, it is important to understand the
repeatability of quantitative PET metrics in order to assess change in tracer uptake. The present stud-
ies were performed in order to assess precision as function of PET/CT system, reconstruction proto-
col, analysis method, scan duration (or image noise), and repositioning in the field of view.
Methods: Multiple (repeated) scans have been performed using a NEMA image quality (IQ) phantom
and a 3D Hoffman brain phantom filled with 18F solutions on two systems. Studies were performed
with and without randomly (< 2 cm) repositioning the phantom and all scans (12 replicates for IQ
phantom and 10 replicates for Hoffman brain phantom) were performed at equal count statistics. For
the NEMA IQ phantom, we studied the recovery coefficients (RC) of the maximum (SUVmax), peak
(SUVpeak), and mean (SUVmean) uptake in each sphere as a function of experimental conditions (noise
level, reconstruction settings, and phantom repositioning). For the 3D Hoffman phantom, the mean
activity concentration was determined within several volumes of interest and activity recovery and its
precision was studied as function of experimental conditions.
Results: The impact of phantom repositioning on RC precision was mainly seen on the Philips Inge-
nuity PET/CT, especially in the case of smaller spheres (< 17 mm diameter, P < 0.05). This effect
was much smaller for the Siemens Biograph system. When exploring SUVmax, SUVpeak, or SUVmean
of the spheres in the NEMA IQ phantom, it was observed that precision depended on phantom repo-
sitioning, reconstruction algorithm, and scan duration, with SUVmax being most and SUVpeak least
sensitive to phantom repositioning. For the brain phantom, regional averaged SUVs were only mini-
mally affected by phantom repositioning (< 2 cm).
Conclusion: The precision of quantitative PET metrics depends on the combination of reconstruc-
tion protocol, data analysis methods and scan duration (scan statistics). Moreover, precision was also
affected by phantom repositioning but its impact depended on the data analysis method in combina-
tion with the reconstructed voxel size (tissue fraction effect). This study suggests that for oncological
PET studies the use of SUVpeak may be preferred over SUVmax because SUVpeak is less sensitive to
patient repositioning/tumor sampling. © 2017 The Authors. Medical Physics published by Wiley Peri-
odicals, Inc. on behalf of American Association of Physicists in Medicine. [https://doi.org/10.1002/
mp.12623]
Key words: 3D Hoffman brain phantom, IQ NEMA phantom, PET/CT, phantom repositioning,
repeatability, reproducibility
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1. INTRODUCTION
[18F]Fluorodeoxyglucose (18F-FDG) positron emission
tomography and computed tomography (PET/CT) is being
used for staging and tumor response assessment in oncol-
ogy.1–7 The analysis of [18F]-FDG8 uptake in tumors can be
performed semiquantitatively using the standard uptake value
(SUV) rather than using visual assessment of relative change.
The main drawback of using SUV is its sensitivity to various
technical factors, such as image reconstruction settings9 and
segmentation strategies.10–12 The impact of different image
acquisition and processing methods on SUV are well under-
stood and to mitigate these effects,13 various standardization
efforts are made, especially in multicenter clinical trials. In
order to yield a high reproducibility, standard operating pro-
cedures (SOPs) or guidelines need to be followed that address
patient preparation, image acquisition and processing, and
data analysis and interpretation. For longitudinal studies, i.e.,
when quantitatively measuring tumor response to therapy, it
is important to understand the precision of the quantitative
metric being used to measure change in tracer uptake. Several
studies have reported14–16 repeatabilities ranging from 10% to
15%, on average. This precision arises from several clinical
and technical contributions, such as uncertainties in adminis-
tered activity, variability in patient preparation and physiolog-
ical condition (blood glucose level) et cetera, and also from
image noise due to variability in scan statistics. Very few
FDG SUV precision studies report within-patient coefficients
of variation less than 10% and it is unclear if this is limited
by technical as opposed to patient-related factors. Technical
limitations have partly been assessed using phantoms filled
with long half-life isotopes and reassessed at multiple PET
centers.17 However, these effects were not yet assessed for
brain protocols using an anthropomorphic brain phantom. In
addition, new reconstruction algorithms have been developed
for clinical PET/CT systems, incorporating the system point
spread function, that are able to improve spatial resolution.
The aim of this study was, therefore, to experimentally
evaluate PET/CT precision dependence on reconstruction
protocol, scan duration, and image analysis methods. Most
importantly we compared to what extent precision of various
quantitative uptake metrics obtained with different recon-
struction protocols, voxel sizes, and scan durations depend
on phantom repositioning versus static placement of the
phantom. These studies were performed for both an oncology
and brain phantom. In most experimental studies reported to
date the repositioning aspect was not included. As partial vol-
ume effects are in part caused by the so-called tissue fraction
effect (voxel size), the actual ‘voxel sampling’ of small
objects may be an additional source of uncertainty. In clinical
longitudinal studies, patients are not repositioned in exactly
the same manner during all scans. Therefore, it is important
to assess these repositioning effects and to determine which
of the analysis methods can mitigate these effects best. To
this end, PET phantoms for quantitative performance assess-
ment were scanned on two different PET/CT systems. The
acquisitions were repeated (n = 12 for IQ phantom and
n = 10 for Hoffman brain phantom) with and without phan-
tom repositioning, while keeping count statistics equivalent
between replicates. Additionally, the acquired data were
reconstructed using various clinically applied reconstruction
protocols and frame durations. All data were analyzed with
common quantitative metrics, such as SUVmax, SUVpeak, or
SUVmean.
2. MATERIALS AND METHODS
2.A. Phantom experiments
Phantom experiments were performed on an Ingenuity
PET/CT scanner (Philips Healthcare, Cleveland, OH, USA)
and the Biograph mCT 40 (Siemens Healthcare, Knoxville,
TN, USA). All emission data were reconstructed using the
vendor-provided time of flight iterative reconstruction
method including all corrections needed for quantification
such as scatter, random, normalization, and attenuation cor-
rection. The Philips Ingenuity system uses an iterative recon-
struction algorithm (BLOB-OS-TF) with 3 iterations and 33
subsets, and the Siemens Biograph system uses a 3D iterative
reconstruction algorithm (OSEM) with 3 iterations and 21
subsets. For both systems, a low-dose CT, using vendor rec-
ommended settings, was used for attenuation correction.
Moreover images were generated with and without point
spread function (PSF) or resolution modeling. For the Philips
Ingenuity PET/CT system, the resolution modeling is imple-
mented as a postreconstruction iterative deconvolution
method (and used with the vendor provided default settings).
The Philips Ingenuity system reconstructs images with a
voxel size of either 4 9 4 9 4 mm3 or 2 9 2 9 2 mm3
with a corresponding matrix of 144 9 144 9 45 or 288 9
288 9 90 for body mode acquisitions. Brain mode acquisi-
tions yield images with a voxel size of 2 9 2 9 2 mm3 and
a matrix of 128 9 128 9 90 (applied only in case of the 3D
Hoffman phantom, as discussed below). Resolution modeling
on the Siemens Biograph system is implemented within the
reconstruction process, i.e., included in the system matrix.
Data collected on the Siemens Biograph PET/CT system are
reconstructed with a voxel size of either 3.1819 9 3.1819 9
2 mm3 or 2.0364 9 2.0364 9 2 mm3 with a corresponding
matrix of 256 9 256 9 111 or 400 9 400 9 111 for body
mode acquisitions. Brain mode acquisitions are reconstructed
with a voxel size of 2.0364 9 2.0364 9 2 mm3 and matrix
of 400 9 400 9 111.
Two different phantoms were evaluated. First, the NEMA
NU-2 Image Quality (IQ) phantom (Data Spectrum, Hillsbor-
ough, NC, USA) was used. This phantom is well known for
its use in NEMA NU-2 IQ PET performance measurements
and for its use in standardization of multicenter PET studies
(EANM-EARL).18 The phantom consists of a large back-
ground volume (9400 mL) with six spheres with inner diam-
eters of 10, 13, 17, 22, 28, and 37 mm. The spheres and the
background were filled with an 18F solution following
EANM/EARL recommendations and resulted in sphere/back-
ground ratios of approximately 10:1. The ‘true’ activity
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concentration in the phantom was derived from the activity
measurement with a dose-calibrator and the known volume
of the phantoms. Moreover, activity concentrations were
cross-checked by measuring samples on a gamma well coun-
ter. Two series of scans were performed for each PET/CT sys-
tem. First, the IQ phantom was filled once (ranging from 1.75
to 3.08 kBq ml1 in the background compartment and 17.78
to 28.63 kBq ml1 in the spheres) and scanned in one fixed
position for 120 min. Data were reconstructed in 12 frames at
three different frame durations (2, 4, and 5 min for the first
reconstructed frame). In order to keep scan statistics constant
between all reconstructed images, frame duration was
increased for each subsequent reconstructed frame to com-
pensate for radioactive decay (i.e., yielding similar count
statistics for each subsequent frame). Secondly, the IQ phan-
tom was filled once and rescanned (both low-dose CT and
PET) 12 times while randomly repositioning the phantom at
different angles along any axis (< 5 degrees) and translations
(x, y, z), resulting in displacements of up to 20 mm. Each of
the acquisitions was reconstructed with frame durations to
yield the same count statistics as achieved with the first set of
(stationary phantom) measurements.
Secondly, we acquired data for the 3D Hoffman brain
phantom (Data Spectrum, Hillsborough, NC, USA). Similar
to the IQ phantom experiment, the phantom was scanned in
two series for each PET/CT system: one using the same phan-
tom position over 120 min (activities ranging from 59.69 to
125 MBq in the phantom at start scanning) and a series
consisting of rescanning at 10 different phantom repositions
(activities ranging from 62.34 to 114 MBq in the phantom at
start scanning). Similar to the IQ phantom studies, data were
reconstructed with three different frame durations (2, 4, and
5 min for the first frame). The frame duration was again
increased to compensate for radioactive decay (i.e., yielding
similar count statistics for each frame).
2.B. Regional assessments
Regional assessment of the experiments was performed
using several automated (IQ Phantom) and manual image
segmentation methods (3D Hoffman phantom). Automated
segmentation of the spheres of the IQ phantom was per-
formed using the EARL analysis tool which generated vol-
umes with background corrected isocontours set at 50% of
SUVmax.
18 From these delineations, we derived the maximum
(SUVmax), peak (SUVpeak), and mean (SUVmean) uptake in
each of the images. The peak SUV was derived from a 1 ml
spherical volume of interest (VOI) positioned to yield the
highest average VOI value across the lesion (or sphere in case
of the phantom). Note that the VOI analysis was performed
on the original images without image registration to resemble
clinical conditions as closely as possible. Next, we derived
the recovery coefficient (RCmax, RCpeak, and RCmean) by
dividing observed max, peak, and mean values by the
expected activity concentrations. RCs were derived for each
sphere and for all acquired and reconstructed emission
images. RCs precision as a function of sphere size, data
analysis method (max, peak, and mean), and reconstruction
methods for both stationary and repositioning phantom exper-
iments was evaluated.
For the 3D Hoffman brain phantom, several volumes of
interest (VOIs) were drawn manually using a coregistered
binary mask of gray and white matter of the phantom. For
each hemisphere in total, five different VOIs for gray and five
VOIs for white matter of different sizes were drawn as shown
in Fig. 1. VOI were chosen to obtain activity concentration
estimates for both cortical and more deeply located brain
structures. From these VOIs, we derived the mean regional
activity concentration and compared these with the actual
activity concentration of the solution used to fill the phantom
to produce the RCmean. For the repositioned phantom study,
this VOI template was rigidly realigned onto the original
phantom images.
3. RESULTS
3.A. NEMA IQ phantom
Figures 2 and 3 illustrate recovery coefficients for the IQ
phantom for images with 5-min scan duration. In general,
repositioning of the phantom increased variability of RC data
compared with the stationary phantom data especially for the
Philips Ingenuity system (Table I). The additional variability
due to repositioning was larger when using RCmax and/or
using reconstructions that include PSF. Also, for both sys-
tems, use of TOF + PSF produced higher recoveries than
TOF reconstruction alone and this effect (> 5% increase) was
largest for RCmax observed with the Siemens Biograph sys-
tem [Fig. 3(b)]. The PSF implementation on the Siemens
Biograph also affects the smaller spheres more as compared
to the implementation on the Philips Ingenuity system, which
resulted in an increased RC and also strongly increased vari-
ability [Figs. 2(b), 2(f), 3(b) and 3(f)]. In supporting informa-
tion Figs. S1 and S2, recovery coefficients observed for the
IQ phantom for images with 2-min scan duration are shown.
Although these RCs showed somewhat larger variability, as
expected due to the lower count statistics as compared to 5-
min data, overall trends were similar to those of the 5-min
data.
Recovery coefficients for images reconstructed with smal-
ler voxel sizes (2 9 2 9 2 mm3) are shown in Figs. 4 and 5
(5-min scan duration) and supporting information Figs. S3
and S4 (2-min scan duration). Comparing the differences
between Fig. 2 and 4 and between Fig. 3 and 5 showed that
smaller voxel sizes result in increased variability in the
observed recoveries. This effect is larger for the Philips Inge-
nuity than for the Siemens Biograph system. For both scan-
ners, the variability of RC was now comparable between
repositioning and stationary phantom experiments (Table II).
Moreover, shorter frame durations increased variability in the
observed recoveries. In general, RCmax was more sensitive to
noise and phantom repositioning than the other quantitative
metrics. Tables I and II summarize the F-test significance
(not corrected for multiple comparisons), for differences in
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precision between the stationary scan and repositioning phan-
tom data for the various analysis methods and voxel sizes.
3.B. 3D Hoffman brain phantom evaluation
Box plots in Fig. 6 demonstrate the RCmean for several
gray matter regions drawn in the Hoffman brain phantom
acquired on the Philips Ingenuity system. There was no sig-
nificant difference in RC variability between repositioned and
stationary scans and when using shorter frame durations (data
not shown). PSF-based reconstructions yielded slightly
higher RCs (~3%). Gray matter recoveries were similar, but
slightly more variable for the repositioning data, on the Sie-
mens Biograph system (data not shown). Figure 7 shows
RCmean for the white matter regions acquired on the Philips
Ingenuity system. For white matter, the Philips Ingenuity sys-
tem showed ~10% lower values than the Siemens Biograph
system. In addition, for the Philips Ingenuity system with
PSF reconstruction, the RC values were slightly lower than
those obtained without PSF in white matter regions, while
the Siemens Biograph system yielded similar results for the
reconstructions with and without PSF.
4. DISCUSSION
4.A. NEMA IQ phantom
The impact of phantom repositioning on RC precision
can clearly be seen in Figs. 2 and 3 (and supporting infor-
mation Figs. S1 and S2), especially in the case of smaller
spheres (< 17 mm diameter, Table I, P < 0.05) for all
analysis methods used. However, this effect was smaller
for the Siemens Biograph system, possibly because of the
smaller voxel sizes in body mode imaging (20.2 mm3)
compared with those used on the Philips Ingenuity system
(64.0 mm3). This finding is supported by reconstructions
with smaller voxel sizes for both systems showing that
phantom repositioning has a smaller impact on RC preci-
sion if smaller voxel sizes (2 9 2 9 2 = 8 mm3) are used
(Figs. 4 and 5, and supporting information Figs. S3 and
S4). Although some of the differences were statistically
significant (Tables I and II), the actual differences are very
small and likely clinically not relevant. In case of smaller
voxels (< 4 9 4 9 4 ~ 64 mm3), the impact of noise (due
to less count per voxel) seems to have a larger effect on
RC variability than that resulting from phantom reposition-
ing. The precision is even worse when shorter scan dura-
tions are used in combination with small voxel sizes as
shown in supplemental Figs. 3 and 4. For all reconstruc-
tions, use of regionally averaged values, such as in case of
RCmean or RCpeak shows less dependence on phantom
repositioning than RCmax. Moreover, it was found that par-
ticularly RCmax shows upward bias with decreasing scan
duration or worse scan statistics, as was shown before by
Boellaard et al.,10 Lodge et al.,19 and Doot et al.17 A pos-
sible strategy to reduce uncertainty caused by scanner dif-
ferences, noise and repositioning could therefore be
achieved by the use of SUVpeak and this method might be
the method of choice for tumor imaging in a clinical set-
ting. Our findings are in good agreement with the study
by Lodge et al.19 suggesting that the peak value is a more
robust metric, not only experimentally20 but also in clinical
practice.19 Moreover, as was shown by Makris et al.,21
SUVpeak depends less on differences in image resolution
and might, therefore, be an attractive method in multicen-
tre studies. A drawback of SUVpeak is the lower recovery
for smaller spheres/tumors when the size of the peak VOI
is equal to or larger than that of the sphere/tumor such
that background activity is included within the VOI. The
latter explains also why for the Siemens data in Fig. 3,
when using PSF during the reconstructions, RCpeak still
show low recoveries for the smallest spheres, while much
higher recoveries were seen for RCmax or RCmean. The low
recoveries of SUVpeak for small spheres (< 12 mm diame-
ter) may hamper its application for very small tumors and
the use of SUVpeak in a longitudinal setting, e.g., to
measure treatment response, therefore warrants further
exploration.
(a) (b)
FIG. 1. Illustration of VOIs in gray matter for both brain hemispheres in (A) and VOIs in white matter in (B). These VOIs were used to assess RC for different
brain structures and regions as function of experimental condition. [Color figure can be viewed at wileyonlinelibrary.com]
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FIG. 2. RC of NEMA IQ phantom data as a function of sphere diameter. Data were acquired on the Philips Ingenuity system and based on images with a
4 9 4 9 4 mm3 voxel size and 5-min starting frame duration using TOF on the left column and TOF + PSF on the right column. Figures (A and B) represent
RC (%) for max, (C and D), peak, and (E and F) mean SUVs. Dotted lines correspond to the true RC based on the true activity within the phantom spheres.
Boxes represent standard deviation (SD), whiskers show ranges, and solid line depicts median of the data.
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FIG. 3. RC of NEMA IQ phantom data as a function of sphere diameter. Data were acquired on the Siemens Biograph system and based on images with a
3.1819 9 3.1819 9 2 mm voxel size and 5-min starting frame duration using TOF on the left column and TOF + PSF on the right column. Figures (A and B)
represent RC (%) for max, (C and D), peak, and (E and F) mean SUVs. Dotted lines correspond to the true RC based on the true activity within the phantom
spheres. Boxes represent standard deviation (SD), whiskers show ranges, and solid line depicts median of the data.
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The choice of acquisition settings and reconstruction algo-
rithm can also heavily affect the quantitative precision. As
expected, shorter scans (i.e., 2-min scan duration) tend to
provide overestimated RCmax which is consistent with the
finding by Boellaard et al.10 and Akamatsu et al.20 Further-
more, data in this study showed an increase in RC variability
from 20 to 30% when using reconstructions that include PSF
for both repositioned and stationary data. Even in the station-
ary phantom study, recoveries varied with reconstruction pro-
tocol which is in agreement with Armstrong et al.22
4.B. Hoffman brain phantom
The Hoffman brain phantom consists of a complex struc-
ture that mimics the structure of the human brain. The mea-
surement of tracer uptake in small brain structures such as the
caudate and putamen can be hampered by partial volume
effects. For the Philips Ingenuity system, the inclusion of the
PSF in the reconstruction increased gray matter region
RCmean up to 5%–10% compared to those seen without PSF.
On the other hand, RCmean in white matter regions was
reduced by 2%–5% when using PSF. These effects found for
the Philips Ingenuity system are consistent with that by Shao
et al.23 The data for the Siemens Biograph system were much
less affected by use of PSF in the brain phantom experiment
(< 2%), although visually images appear to have a higher res-
olution. These results can be expected as the use of PSF
results in improved spatial resolution and should, therefore,
result in higher recoveries in gray matter structures and lower
ones for white matter. However, it should be noted that use of
PSF may introduce Gibbs artifacts as well, which in turn
could lead to activity concentration overestimations.24
Statistical analysis performed on the data from the Philips
system showed a significant difference between repositioned
and stationary phantoms scans for both gray and white matter
VOIs. However, the differences were very small (< 5%) and
likely not clinically relevant. The low sensitivity of RC
variability for phantom repositioning likely results from the
use of regionally averaged values. This was also observed in
the NEMA IQ phantom, where SUVmean seems to be less
sensitive to phantom (re-)positioning than SUVmax. There-
fore, spatially averaging data over an extended volume of
interest seems to mitigate the effects of phantom reposition-
ing and/or (voxel) sampling of the phantom. Although the
distribution of the radiotracer in the Hoffman brain phantom
is assumed to be uniform within gray and white matter
regions, the distribution in a real human brain might exhibit
larger variations. Therefore, it cannot be ruled out that there
is an effect of patient repositioning on the precision of regio-
nal average values in clinical practice.
4.C. Future perspectives
This study confirms several findings from previous stud-
ies, such as precision dependence on scan statistics/duration,
data analysis methods and reconstruction protocol, and may
therefore be assumed to be generally applicable. In our work,
we extended earlier studies by including the effects of reposi-
tioning in order to resemble the clinical conditions encoun-
tered in longitudinal studies for both oncology body scans as
well as brain PET studies. We found that phantom reposition-
ing and thereby tumor voxel sampling variations particularly
affected the precision of SUVmax analysis for small spheres,
while the use of regionally averaged values by SUVpeak or
SUVmean mitigated these uncertainties (in part). The latter
can be understood easily as averaging data over multiple vox-
els mitigate some of the sampling effect. In particular, use of
a fixed size VOI, such as SUVpeak, generates uptake values
that can be expected to be less influenced by voxel size pro-
vided fractional voxel coverage by the SUVpeak is taken into
account appropriately, as was the case in this study.
A limitation of our work was the use of random reposi-
tioning of the phantom rather than applying systematic dis-
placements in axial and transaxial directions. The latter
TABLE I. Significant P values (not corrected for multiple comparisons) calculated by performing F-tests between repositioned and stationary phantom datasets
for different analysis and reconstruction methods and for each sphere and for 5-min scan duration data with 4 9 4 9 4 mm3 voxel sizes for the Philips Ingenuity




(SUVmax) TOF + PSF (SUVmax) TOF (SUVpeak) TOF + PSF (SUVpeak) TOF (SUVmean)
TOF + PSF
(SUVmean)
Philips ingenuity 10 0.001 0.001 0.001 0.010 0.053 0.013
13 0.002 0.002 – – 0.036 0.034
17 0.018 4.5 9 108 0.002 1.2 9 108 0.003 4.08 9 108
22 – – – – – –
28 – – – – – –
37 – – – – – –
Siemens
biograph mCT40
10 – 0.001 – 0.006 – 0.01
13 – – – 0.009 – –
17 0.001 – 0.001 – 0.003 –
22 0.001 0.040 0.004 0.030 0.002 0.032
28 0.013 – 0.003 – 0.001 0.001
37 – 0.001 – – – –
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FIG. 4. RC of NEMA IQ phantom data as a function of sphere diameter. Data were acquired on the Philips Ingenuity system and based on images with a
2 9 2 9 2 mm3 voxel size and 5-min starting frame duration using TOF on the left column and TOF + PSF on the right column. Figures (A and B) represent
RC (%) for max, (C and D), peak, and (E and F) mean SUVs. Dotted lines correspond to the true RC based on the true activity within the phantom spheres.
Boxes represent standard deviation (SD), whiskers show ranges, and solid line depicts median of the data.
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FIG. 5. RC of NEMA IQ phantom data as a function of sphere diameter. Data were acquired on the Siemens Biograph system and based on images with a
2 9 2 9 2 mm3 voxel size and 5-min starting frame duration using TOF on the left column and TOF + PSF on the right column. Figures (A and B) represent
RC (%) for max, (C and D), peak, and (E and F) mean SUVs. Dotted lines correspond to the true RC based on the true activity within the phantom spheres.
Boxes represent standard deviation (SD), whiskers show ranges, and solid line depicts median of the data.
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would have allowed to determining the effect of axial versus
transaxial resolution of the system on the observed preci-
sions. In our study, we have chosen to randomly reposition
the phantom to resemble clinical practice and we assumed
that use of 12 or 10 replicates would provide sufficient under-
standing of PET uncertainty dependence on phantom reposi-
tioning as our results are in line with previous reports (using
non-PSF reconstructions17).
Secondly, in our paper, we focused only on some technical
aspects or factors that could affect PET precision. Yet, there
are many other sources of uncertainty in clinical practice,25
such as net injected activity, patient preparation procedures,
uptake time variability, use of different data analysis software,
scanner calibration errors, etc. that may have a much larger
effect on PET precision than the effect of e.g., repositioning.
The observed increased variability of SUVmax with IQ phan-
tom repositioning is small compared to the uncertainties
resulting from other factors, in particular when PET studies
are not strictly performed in compliance with international
guidelines. Yet, the authors believe that by using quantitative
TABLE II. Significant P values (not corrected for multiple comparisons) calculated by performing F-tests between repositioned and stationary phantom datasets
for different analysis and reconstruction methods and for each sphere and for 5-min scan duration data with 2 9 2 9 2 mm3 voxel sizes for both the Philips Inge-




(SUVmax) TOF (SUVpeak) TOF + PSF (SUVpeak) TOF (SUVmean) TOF + PSF (SUVmean)
Philips ingenuity 10 0.006 – – – – –
13 0.005 – – – – –
17 0.010 – – – – 0.002
22 0.001 – – – – –
28 – – 0.021 0.028 0.003 0.009
37 0.016 – – – – –
Siemens
biograph mCT40
10 0.046 0.011 0.025 – 0.032 0.020
13 – – 0.008 – – –
17 0.024 – – – – –
22 0.001 0.004 0.001 0.027 0.001 0.004
28 0.007 0.001 0.003 0.047 0.000 0.001
37 – 0.011 – – – 0.021
FIG. 6. RC (%) of Hoffman phantom data in different gray matter regions. Data were acquired on the Philips Ingenuity system and reconstructed using TOF (A)
and TOF + PSF (B). RC for 5-min frame duration are shown. Boxes represent standard deviation (SD), whiskers show ranges, and solid line depicts median of
the data.
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metrics, such as SUVpeak, that may mitigate even relatively
small sources of error could improve the repeatability and
reproducibility of quantitative PET reads and are worth fur-
ther exploration.
5. CONCLUSIONS
Precision of quantitative tracer uptake values depends on
scan duration, data analysis methods, reconstruction protocol,
and phantom repositioning. The latter effect was most pro-
nounced in an oncological experimental phantom setting for
smaller spheres (< 15 mm diameter) when using SUVmax.
When using either fixed sized VOIs (SUVpeak in the IQ phan-
tom) or using regionally averaged data (brain phantom), the
impact of phantom repositioning on quantitative precision is
minimal. As in longitudinal studies it is impossible to exactly
put the patient in the same position in the PET/CT system, it
would be preferred to quantify tracer uptake using methods
that are insensitive to patient repositioning. The use of
SUVpeak in an oncological setting may, therefore, be a good
alternative to SUVmax, but its use for smaller lesions needs to
be further studied due to the lower recoveries seen for spheres
smaller than 15 mm diameter.
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Fig. S1. RC of NEMA IQ phantom data as a function of
sphere diameter. Data acquired on the Philips Ingenuity sys-
tem and based on images with a 4 9 4 9 4 mm3 voxel size
and 2-min starting frame duration using TOF on the left col-
umn and TOF + PSF on the right column. Figures (A and B)
represent RC (%) for max, (C and D), peak, and (E and F)
mean SUVs. Dotted lines correspond to the true RC based on
the true activity within the phantom spheres. Boxes represent
standard deviation (SD), whiskers show ranges, and solid line
depicts median of the data.
Fig. S2. RC of NEMA IQ phantom data as a function of
sphere diameter. Data acquired on the Siemens Biograph sys-
tem and based on images with a 3.1819 9 3.1819 9 2 mm
voxel size and 2-min starting frame duration using TOF on
the left column and TOF + PSF on the right column. Figures
(A and B) represent RC (%) for max, (C and D), peak and (E
and F) mean SUVs. Dotted lines correspond to the true RC
based on the true activity within the phantom spheres. Boxes
represent standard deviation (SD), whiskers show ranges, and
solid line depicts median of the data.
Fig. S3. Maximum RC (%) of NEMA IQ phantom data as a
function of sphere diameter. Data acquired on the Philips
Ingenuity system and based on images with a
2 9 2 9 2 mm3 voxel size and 2-min starting frame dura-
tion using TOF on the left and TOF + PSF on the right. Dot-
ted lines correspond to the true RC based on the true activity
within the phantom spheres. Boxes represent standard devia-
tion (SD), whiskers show ranges, and solid line depicts med-
ian of the data.
Fig. S4. Maximum RC (%) of NEMA IQ phantom data as a
function of sphere diameter. Data acquired on the Siemens
Biograph system and based on images with a
2 9 2 9 2 mm3 voxel size and 2-min starting frame dura-
tion using TOF on the left and TOF + PSF on the right. Dot-
ted lines correspond to the true RC based on the true activity
within the phantom spheres. Boxes represent standard devia-
tion (SD), whiskers show ranges, and solid line depicts med-
ian of the data.
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